[Double blind test for objective evaluation of the therapeutic effect of Coroverlan].
D000368:Aged; D001216:Asparagine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D005853:Geriatrics; D006331:Heart Diseases / Q000188:drug therapy*; D006801:Humans; D008274:Magnesium / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010634:Phenobarbital / Q000627:therapeutic use; D010919:Placebos; D010946:Plants, Medicinal; D011188:Potassium / Q000627:therapeutic use; D013806:Theophylline / Q000627:therapeutic use*
D010919:Placebos; D001216:Asparagine; D013806:Theophylline; D008274:Magnesium; D011188:Potassium; D010634:Phenobarbital
Doppelter Blindversuch zur Objektivierung des therapeutischen Effektes von Coroverlan.